Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
0.9751
-0.0239 (-2.39%)
Aug 14, 2025, 11:47 AM - Market open
Coherus Oncology Employees
Coherus Oncology had 228 employees as of December 31, 2024. The number of employees decreased by 78 or -25.49% compared to the previous year.
Employees
228
Change (1Y)
-78
Growth (1Y)
-25.49%
Revenue / Employee
$1,193,899
Profits / Employee
$788,382
Market Cap
113.33M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CHRS News
- 5 days ago - Coherus Oncology, Inc. (CHRS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 13 days ago - Coherus Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 3 months ago - Coherus BioSciences, Inc. (CHRS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Coherus to Report First Quarter 2025 Financial Results on May 12, 2025 - GlobeNewsWire
- 3 months ago - Coherus to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Coherus Presents Promising Early Clinical Data from Phase 1 Dose Expansion Study of CHS-114 in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at AACR 2025 - GlobeNewsWire